Ig class-switch recombination (CSR) is a region-specific process that exchanges the constant Ig heavy-chain region and thus modifies an antibody's effector function. DNA lesions in switch (S) regions are induced by activation-induced cytidine deaminase (AID) and uracil-DNA glycosylase 2 (UNG2), subsequently processed to DNA breaks, and resolved by either the classical nonhomologous endjoining pathway or the alternative end-joining pathway (XRCC4/ DNA ligase 4-and/or Ku70/Ku80-independent and prone to increased microhomology usage). We examined whether the induction of DNA lesions influences DNA end-joining during CSR by analyzing Sμ-Sα recombination junctions in various human Ig CSR defects of DNA lesion induction. We observed a progressive trend toward the usage of microhomology in Sμ-Sα recombination junctions from AID-heterozygous to AID-autosomal dominant to UNG2-deficient B lymphocytes. We thus hypothesize that impaired induction of DNA lesions in S regions during CSR leads to unusual end-processing of the DNA breaks, resulting in microhomology-mediated end-joining, which could be an indication for preferential processing by alternative end-joining rather than by classical nonhomologous end-joining.antibody maturation | switch junction | DNA repair D uring immune responses, mature B cells diversify their Ig genes through class-switch recombination (CSR) and somatic hypermutation (SHM). The latter mechanism introduces nontemplated point mutations in the variable region of Ig genes and thereby enables the selection of antibodies with increased affinity for the antigen. CSR modulates antibody effector function by replacing one constant region with another in a deletionmediated recombination process, while retaining the binding specificity (variable region) of the B-cell receptor. Both processes are initiated by the enzyme activation-induced cytidine deaminase (AID), which deaminates cytosine to produce U:G mismatches in target DNA (1-3). GC-rich regions, so-called "switch" (S) regions, present in front of each constant region and of varying lengths, are the target DNAs for AID during CSR. The main route for processing AID-induced lesions involves uracil excision through several pathways, primarily the pathway involving uracil-DNA glycosylase (UNG2) (4, 5). Abasic sites are further processed to generate DNA double-strand breaks (DSBs), which are obligate intermediates in CSR (6, 7). The DSBs activate damage response proteins, such as PI3-like protein kinase ataxia-telangiectasia mutated, the phosphorylated histone variant H2AX, the MRN complex (MRE11, RAD50, and NBS1), MDC1, and 53BP1, all of which are known to play roles in CSR in promoting appropriate repair and efficient long-range, region-specific recombination (8)(9)(10)(11)(12)(13)(14). In CSR, the resolution step is normally mediated by the classical nonhomologous end-joining pathway (c-NHEJ); however, recent reports strongly suggest that resolution also can be mediated (albeit at a lower frequency) by Ku 70-, Ku 80-, and/or XRCC4/DNA ligase 4-independen...